Quick Answer
RetinalGenix Technologies Inc. reported Net Income Loss of -$4.32 million for the year ending 2024.
- RetinalGenix Technologies Inc. showed a decrease of -106.7% in Net Income Loss from 2023 to 2024.
- This data is from RetinalGenix Technologies Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: -$466.8 thousand | Q2 2020: -$430.9 thousand | Q3 2020: -$567.1 thousand | Q1 2021: -$683.7 thousand | Q2 2021: -$534.9 thousand | Q3 2021: -$551.0 thousand | Q1 2022: -$375.2 thousand | Q2 2022: -$359.3 thousand | Q3 2022: -$2.50 million | Q1 2023: -$510.6 thousand | Q2 2023: -$352.1 thousand | Q3 2023: -$686.5 thousand | Q1 2024: -$2.15 million | Q2 2024: -$663.6 thousand | Q3 2024: -$644.3 thousand | Q1 2025: -$587.3 thousand | Q2 2025: -$649.4 thousand | Q3 2025: -$568.8 thousand.
- Over the full 5 years of available data (2020 to 2024), RetinalGenix Technologies Inc.'s Net Income Loss has declined by 107.9%.
- Historical annual values: Fiscal year 2024: -$4.32 million | Fiscal year 2023: -$2.09 million | Fiscal year 2022: -$3.91 million | Fiscal year 2021: -$2.18 million | Fiscal year 2020: -$2.08 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: